We are live on ! Find out more
JGGDR

JGP Global Gestao de Recursos Portfolio holdings

AUM $45.3M
1-Year Est. Return 42.75%
This Fund
S&P 500
This Quarter Est. Return
+28.14%
1 Year Est. Return
+42.75%
3 Year Est. Return
+205.51%
5 Year Est. Return
+441.7%
10 Year Est. Return
+707.39%
AUM
$172M
AUM Growth
-$32.4M
Cap. Flow
-$73.3M
Cap. Flow %
-42.6%
Top 10 Hldgs %
95.85%
Holding
47
New
2
Increased
15
Reduced
17
Closed
13

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$8.19K
2
ABBV icon
AbbVie
ABBV
+$5.7K
3
JNJ icon
Johnson & Johnson
JNJ
+$5.31K
4
ABT icon
Abbott
ABT
+$3.54K
5
BSX icon
Boston Scientific
BSX
+$2.9K

Sector Composition

Rank Sector Weight
1 Materials 43.91%
2 Technology 36.01%
3 Financials 13.13%
4 Healthcare 6.51%
5 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NGD
1
DELISTED
New Gold Inc
NGD
$75.5M 43.91%
10,516,700
-71,297
-0.7% -$386K
STNE icon
2
StoneCo
STNE
$2.67B
$60.8M 35.36%
3,215,966
-1,338,359
-29% -$21.3M
XP icon
3
XP
XP
$8.43B
$11.3M 6.57%
601,071
-253,181
-30% -$4.54M
NU icon
4
Nu Holdings
NU
$67.8B
$11.3M 6.56%
704,467
-64,452
-8% -$899K
ONC
5
BeOne Medicines Ltd
ONC
$33.9B
$1.75M 1.02%
5,142
-6,853
-57% -$2.08M
INCY icon
6
Incyte
INCY
$25.4B
$1.4M 0.82%
16,542
-2,790
-14% -$221K
LLY icon
7
Eli Lilly
LLY
$1.08T
$1.03M 0.6%
1,352
+11
+0.8% +$8.19K
ABBV icon
8
AbbVie
ABBV
$465B
$781K 0.45%
3,374
+28
+0.8% +$5.7K
ACAD icon
9
Acadia Pharmaceuticals
ACAD
$4.51B
$493K 0.29%
23,082
-3,870
-14% -$91.5K
MDGL icon
10
Madrigal Pharmaceuticals
MDGL
$12.6B
$478K 0.28%
1,042
-199
-16% -$74.2K
VNET
11
CALL
VNET Group
VNET
$1.79B
$470K 0.27%
+2,000
New +$16.8K
ABT icon
12
Abbott
ABT
$188B
$451K 0.26%
3,364
+27
+0.8% +$3.54K
TSM icon
13
TSMC
TSM
$1.94T
$448K 0.26%
1,604
-558
-26% -$136K
NVDA icon
14
NVIDIA
NVDA
$4.6T
$438K 0.25%
2,347
-4,737
-67% -$826K
JNJ icon
15
Johnson & Johnson
JNJ
$640B
$434K 0.25%
2,338
+31
+1% +$5.31K
INSM icon
16
Insmed
INSM
$22.4B
$388K 0.23%
2,697
-450
-14% -$55.1K
TMO icon
17
Thermo Fisher Scientific
TMO
$214B
$373K 0.22%
769
+6
+0.8% +$2.79K
ISRG icon
18
Intuitive Surgical
ISRG
$127B
$366K 0.21%
819
+6
+0.7% +$2.88K
BSX icon
19
Boston Scientific
BSX
$68.4B
$351K 0.2%
3,592
+28
+0.8% +$2.9K
UNH icon
20
UnitedHealth
UNH
$382B
$343K 0.2%
992
+8
+0.8% +$2.42K
RYTM icon
21
Rhythm Pharmaceuticals
RYTM
$7.31B
$329K 0.19%
3,253
-571
-15% -$53K
BMY icon
22
Bristol-Myers Squibb
BMY
$129B
$306K 0.18%
6,774
+58
+0.9% +$2.71K
ZTS icon
23
Zoetis
ZTS
$32.7B
$289K 0.17%
1,977
+15
+0.8% +$2.27K
GILD icon
24
Gilead Sciences
GILD
$165B
$285K 0.17%
2,566
+21
+0.8% +$2.39K
DHR icon
25
Danaher
DHR
$138B
$270K 0.16%
1,361
+11
+0.8% +$2.19K

Similar funds

JGP Global Gestao de Recursos's Q3 2025 Portfolio in Review

As of Q3 2025, JGP Global Gestao de Recursos held 47 positions worth $172M, down 16% from $204M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

JGP Global Gestao de Recursos withdrew a net $73.3M in Q3 2025, closing 13 positions and reducing 17 holdings. Its most notable exit was Kratos Defense & Security Solutions, an estimated $17.9M position sold in full.

By sector, the portfolio is most concentrated in Materials at 44% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, JGP Global Gestao de Recursos added an estimated $8.19K to Eli Lilly.

  • JGP Global Gestao de Recursos added most to Eli Lilly in Q3 2025, an estimated $8.19K increase.
  • JGP Global Gestao de Recursos's biggest Q3 2025 reduction was StoneCo, cutting an estimated $21.3M.
  • JGP Global Gestao de Recursos fully exited Kratos Defense & Security Solutions in Q3 2025, selling an estimated $17.9M.
  • JGP Global Gestao de Recursos's ten largest holdings make up 96% of its $172M portfolio in Q3 2025.
  • JGP Global Gestao de Recursos opened 2 new positions and closed 13 in Q3 2025.
  • JGP Global Gestao de Recursos's portfolio value fell 16% quarter-over-quarter to $172M.

Based on JGP Global Gestao de Recursos's 13F filing for Q3 2025, filed 24 Oct 2025.